Skip to content

Section archive

Aspirin

A Lancet meta-analysis found people who took daily aspirin for more than four years reduced their chance of dying of cancer by 21 percent, with esophageal and throat cancer down 60 percent and colorectal 40 percent. Rosenberg weighs this against Vioxx, once billed as a safer aspirin.

2 min read

3 stories